The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.
StarDrop™ is a complete package of fully integrated, elegant software for small molecule design, optimisation and data analysis.
Keep up to date
News & Events
Optibrium appoints Professor Andy Black as non-executive Chair Appointment brings extensive pharmaceutical services and Board experience to drive commercial growth and development of new products to improve speed, efficiency, and productivity of drug ... Read More
Optibrium Releases 3D Ligand-based Design Modulefor StarDrop Drug Discovery Software Innovative predictive methods support virtual screening and compound design in the absence of 3D structure data. CAMBRIDGE, UK, 9 September 2021 – Optibrium Limited, a developer of ... Read More
Optibrium Publishes Major Peer-Reviewed Studyon AI Applications to Global Pharma Data Published in AI Letters, the study collaborators Optibrium, Takeda and Intellegens, demonstrated the application of deep learning imputation to a global pharma dataset, offering ... Read More
16 November 4.00pm (UK): Why have generative chemistry methods not redefined modern drug discovery and compound idea generation? We will shed light on a shortcoming of generative methods of how to prioritise promising directions for exploration.
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of drug discovery. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotechs and academic groups.
Got an Enquiry?
Get In Touch
If you are interested in finding out more about Optibrium or any of our products or services, please do not hesitate to contact us using the contact form. Further details on our office locations and other contact details can be found on our Contact page.